75 related articles for article (PubMed ID: 15517892)
41. Transient PI3K inhibition induces apoptosis and overcomes HGF-mediated resistance to EGFR-TKIs in EGFR mutant lung cancer.
Donev IS; Wang W; Yamada T; Li Q; Takeuchi S; Matsumoto K; Yamori T; Nishioka Y; Sone S; Yano S
Clin Cancer Res; 2011 Apr; 17(8):2260-9. PubMed ID: 21220474
[TBL] [Abstract][Full Text] [Related]
42. The effects of cetuximab alone and in combination with radiation and/or chemotherapy in lung cancer.
Raben D; Helfrich B; Chan DC; Ciardiello F; Zhao L; Franklin W; Barón AE; Zeng C; Johnson TK; Bunn PA
Clin Cancer Res; 2005 Jan; 11(2 Pt 1):795-805. PubMed ID: 15701870
[TBL] [Abstract][Full Text] [Related]
43. Herbal diterpenoids induce growth arrest and apoptosis in colon cancer cells with increased expression of the nonsteroidal anti-inflammatory drug-activated gene.
Ko JK; Leung WC; Ho WK; Chiu P
Eur J Pharmacol; 2007 Mar; 559(1):1-13. PubMed ID: 17258704
[TBL] [Abstract][Full Text] [Related]
44. The bisphosphonate zoledronic acid inhibits the growth of HCT-116 colon carcinoma cells and induces tumor cell apoptosis.
Sewing L; Steinberg F; Schmidt H; Göke R
Apoptosis; 2008 Jun; 13(6):782-9. PubMed ID: 18437576
[TBL] [Abstract][Full Text] [Related]
45. Reduced expression of epidermal growth factor receptor related protein in gastric cancer.
Moon WS; Tarnawski AS; Chai J; Yang JT; Majumdar AP
Gut; 2005 Feb; 54(2):201-6. PubMed ID: 15647181
[TBL] [Abstract][Full Text] [Related]
46. Expression of epidermal growth factor-receptor related protein (ERRP) in human colorectal carcinogenesis.
Jaszewski R; Levi E; Sochacki P; Frank J; Kucuk O; Axelrod BN; Majumdar AP
Cancer Lett; 2004 Sep; 213(2):249-55. PubMed ID: 15327841
[TBL] [Abstract][Full Text] [Related]
47. Expression of EGF-receptor related protein (ERRP) decreases in gastric mucosa during aging and carcinogenesis.
Majumdar AP; Du J; Hatfield JS; Levi E; Adsay V; Schmelz EM; Nagothu KK; Jaszewski R; Kucuk O; Sarkar FH
Dig Dis Sci; 2003 May; 48(5):856-64. PubMed ID: 12772780
[TBL] [Abstract][Full Text] [Related]
48. CysLT(1)R antagonists inhibit tumor growth in a xenograft model of colon cancer.
Savari S; Liu M; Zhang Y; Sime W; Sjölander A
PLoS One; 2013; 8(9):e73466. PubMed ID: 24039952
[TBL] [Abstract][Full Text] [Related]
49. Reduced expression of epidermal growth factor receptor-related protein in hepatocellular carcinoma: implications for cancer growth.
Moon WS; Chang KJ; Majumdar AP; Tarnawski AS
Digestion; 2004; 69(4):219-24. PubMed ID: 15205570
[TBL] [Abstract][Full Text] [Related]
50. Epidermal growth factor receptor-related protein: a potential therapeutic agent for colorectal cancer.
Marciniak DJ; Moragoda L; Mohammad RM; Yu Y; Nagothu KK; Aboukameel A; Sarkar FH; Adsay VN; Rishi AK; Majumdar AP
Gastroenterology; 2003 May; 124(5):1337-47. PubMed ID: 12730874
[TBL] [Abstract][Full Text] [Related]
51. A recombinant fungal compound induces anti-proliferative and pro-apoptotic effects on colon cancer cells.
Nimri L; Spivak O; Tal D; Schälling D; Peri I; Graeve L; Salame TM; Yarden O; Hadar Y; Schwartz B
Oncotarget; 2017 Apr; 8(17):28854-28864. PubMed ID: 28416764
[TBL] [Abstract][Full Text] [Related]
52. Identification of pinostilbene as a major colonic metabolite of pterostilbene and its inhibitory effects on colon cancer cells.
Sun Y; Wu X; Cai X; Song M; Zheng J; Pan C; Qiu P; Zhang L; Zhou S; Tang Z; Xiao H
Mol Nutr Food Res; 2016 Sep; 60(9):1924-32. PubMed ID: 26990242
[TBL] [Abstract][Full Text] [Related]
53. Translational research of a novel humanized epidermal growth factor receptor-related protein: a putative inhibitor of pan-ErbB.
Fu XH; Li J; Huang JJ; Zheng S; Zhang SZ
Cancer Chemother Pharmacol; 2011 Dec; 68(6):1373-6. PubMed ID: 21947130
[TBL] [Abstract][Full Text] [Related]
54. Nerolidol, Bioactive Compound Suppress Growth of HCT-116 Colorectal Cancer Cells Through Cell Cycle Arrest and Induction of Apoptosis.
Zhao X; Chinnathambi A; Alharbi SA; Natarajan N; Raman M
Appl Biochem Biotechnol; 2024 Mar; 196(3):1365-1375. PubMed ID: 37395945
[TBL] [Abstract][Full Text] [Related]
55. Remarkable inhibitory effects of hybrid liposomes on growth of human colon cancer cells through induction of cell cycle arrest along with apoptosis.
Komizu Y; Ueoka H; Goto K; Ueoka R
Int J Nanomedicine; 2011; 6():1913-20. PubMed ID: 21931486
[TBL] [Abstract][Full Text] [Related]
56. Epibrassinolide impaired colon tumor progression and induced autophagy in SCID mouse xenograft model via acting on cell cycle progression without affecting endoplasmic reticulum stress observed in vitro.
Obakan Yerlikaya P; Adacan K; Karatug Kacar A; Coker Gurkan A; Arisan ED
Int J Biochem Cell Biol; 2023 Feb; 155():106360. PubMed ID: 36587800
[TBL] [Abstract][Full Text] [Related]
57. Study of Malformin C, a Fungal Source Cyclic Pentapeptide, as an Anti-Cancer Drug.
Wang J; Jiang Z; Lam W; Gullen EA; Yu Z; Wei Y; Wang L; Zeiss C; Beck A; Cheng EC; Wu C; Cheng YC; Zhang Y
PLoS One; 2015; 10(11):e0140069. PubMed ID: 26540166
[TBL] [Abstract][Full Text] [Related]
58. ErbB-inhibitory protein: a modified ectodomain of epidermal growth factor receptor synergizes with dasatinib to inhibit growth of breast cancer cells.
Nautiyal J; Yu Y; Aboukameel A; Kanwar SS; Das JK; Du J; Patel BB; Sarkar FH; Rishi AK; Mohammad RM; Majumdar AP
Mol Cancer Ther; 2010 Jun; 9(6):1503-14. PubMed ID: 20515951
[TBL] [Abstract][Full Text] [Related]
59. Curcumin enhances dasatinib-induced inhibition of growth and transformation of colon cancer cells.
Nautiyal J; Banerjee S; Kanwar SS; Yu Y; Patel BB; Sarkar FH; Majumdar AP
Int J Cancer; 2011 Feb; 128(4):951-61. PubMed ID: 20473900
[TBL] [Abstract][Full Text] [Related]
60. Emerging therapies in gastrointestinal cancers.
Nautiyal J; Rishi AK; Majumdar AP
World J Gastroenterol; 2006 Dec; 12(46):7440-50. PubMed ID: 17167831
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
